Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

The Effect of Using Virtual Reality Glasses During Coronary Angiography

NCT: NCT04521660 · TERMINATED

NCT IDNCT04521660
StatusTERMINATED
Start Date2020-11-20
Completion2022-02-01
SponsorSaglik Bilimleri Universitesi (OTHER)
First posted
Last updated

Brief Summary

Coronary angiography (CAG) is a diagnostic method used as the gold standard in the diagnosis of coronary artery disease (CAD), which is increasingly prevalent in developed and developing countries and is one of the leading causes of morbidity and mortality in the world. Although coronary angiography is one of the best diagnostic methods of CAD, it can cause psychological problems such as stress, fear, anxiety in patients; It also causes physical problems such as bleeding, hematom and pain. Pharmacological and non-pharmacological methods are used by nurses to solve problems of patients, to ensure their relaxation and to improve their quality of life. With the development of technology, virtual reality (VR) glasses have been used to have fun at first, and later to provide pain management and to solve anxiety problems. VR glasses are an advanced technology that allows the patient to move into a virtual world and focus his attention on other thoughts, giving less attention to pain and anxiety. During literature search, no studies were found about the effect of using SG glasses on pain and anxiety during CAG. This research will be conducted to determine the effect of VR glasses used during CAG on pain, anxiety and hemodynamic parameters of patients who will experience coronary angiography for the first time.

Frequently Asked Questions

What is The Effect of Using Virtual Reality Glasses During Coronary Angiography?

The Effect of Using Virtual Reality Glasses During Coronary Angiography is a clinical trial registered under NCT04521660. Current status: TERMINATED.

What is the status of NCT04521660?

The current status of NCT04521660 (The Effect of Using Virtual Reality Glasses During Coronary Angiography) is: TERMINATED.

When did The Effect of Using Virtual Reality Glasses During Coronary Angiography start?

The Effect of Using Virtual Reality Glasses During Coronary Angiography started on 2020-11-20.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑